Regulation of Acinetobacter baumannii biofilm formation
- PMID: 19327114
- PMCID: PMC2724675
- DOI: 10.2217/fmb.09.5
Regulation of Acinetobacter baumannii biofilm formation
Abstract
Acinetobacter baumannii is a Gram-negative opportunistic nosocomial pathogen. This microorganism survives in hospital environments despite unfavorable conditions such as desiccation, nutrient starvation and antimicrobial treatments. It is hypothesized that its ability to persist in these environments, as well as its virulence, is a result of its capacity to form biofilms. A. baumannii forms biofilms on abiotic surfaces such as polystyrene and glass as well as biotic surfaces such as epithelial cells and fungal filaments. Pili assembly and production of the Bap surface-adhesion protein play a role in biofilm initiation and maturation after initial attachment to abiotic surfaces. Furthermore, the adhesion and biofilm phenotypes of some clinical isolates seem to be related to the presence of broad-spectrum antibiotic resistance. The regulation of the formation and development of these biofilms is as diverse as the surfaces on which this bacterium persists and as the cellular components that participate in this programmed multistep process. The regulatory processes associated with biofilm formation include sensing of bacterial cell density, the presence of different nutrients and the concentration of free cations available to bacterial cells. Some of these extracellular signals may be sensed by two-component regulatory systems such as BfmRS. This transcriptional regulatory system activates the expression of the usher-chaperone assembly system responsible for the production of pili, needed for cell attachment and biofilm formation on polystyrene surfaces. However, such a system is not required for biofilm formation on abiotic surfaces when cells are cultured in chemically defined media. Interestingly, the BfmRS system also controls cell morphology under particular culture conditions.
Conflict of interest statement
Figures

Similar articles
-
The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells.Infect Immun. 2009 Aug;77(8):3150-60. doi: 10.1128/IAI.00096-09. Epub 2009 May 26. Infect Immun. 2009. PMID: 19470746 Free PMC article.
-
Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system.Microbiology (Reading). 2003 Dec;149(Pt 12):3473-3484. doi: 10.1099/mic.0.26541-0. Microbiology (Reading). 2003. PMID: 14663080
-
Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.Clin Microbiol Infect. 2008 Jan;14(1):49-54. doi: 10.1111/j.1469-0691.2007.01842.x. Epub 2007 Nov 13. Clin Microbiol Infect. 2008. PMID: 18005176
-
Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development.J Appl Microbiol. 2020 Jan;128(1):15-27. doi: 10.1111/jam.14330. Epub 2019 Jun 26. J Appl Microbiol. 2020. PMID: 31102552 Review.
-
Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies.Eur J Clin Microbiol Infect Dis. 2023 Dec;42(12):1405-1423. doi: 10.1007/s10096-023-04677-8. Epub 2023 Oct 28. Eur J Clin Microbiol Infect Dis. 2023. PMID: 37897520 Free PMC article. Review.
Cited by
-
Global Dynamic Proteome Study of a Pellicle-forming Acinetobacter baumannii Strain.Mol Cell Proteomics. 2017 Jan;16(1):100-112. doi: 10.1074/mcp.M116.061044. Epub 2016 Oct 31. Mol Cell Proteomics. 2017. PMID: 27799293 Free PMC article.
-
The deficiency of poly-β-1,6-N-acetyl-glucosamine deacetylase trigger A. baumannii to convert to biofilm-independent colistin-tolerant cells.Sci Rep. 2023 Feb 16;13(1):2800. doi: 10.1038/s41598-023-30065-5. Sci Rep. 2023. PMID: 36797306 Free PMC article.
-
Decoding Acinetobacter baumannii biofilm dynamics and associated protein markers: proteomic and bioinformatics approach.Arch Microbiol. 2022 Mar 3;204(4):200. doi: 10.1007/s00203-022-02807-y. Arch Microbiol. 2022. PMID: 35239017
-
Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections.Eur J Clin Microbiol Infect Dis. 2020 Sep;39(9):1687-1702. doi: 10.1007/s10096-020-03882-z. Epub 2020 Apr 23. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32328851 Free PMC article.
-
Iron and Acinetobacter baumannii Biofilm Formation.Pathogens. 2014 Aug 18;3(3):704-19. doi: 10.3390/pathogens3030704. Pathogens. 2014. PMID: 25438019 Free PMC article.
References
Bibliography
-
- Juni E. Genus II Acinetobacter. In: Brenner DJ, Krieg NR, Staley JT, editors. Bergey's Manual of Systematic Bacteriology. Springer Science & Business Media, Inc.; New York, USA: 2005. pp. 425–437.
-
▪▪ Overview of Acinetobacter taxonomy and the clinical significance of the genus.
-
- Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939–951. - PubMed
-
▪▪ Excellent overview of methods used for the taxonomy of acinetobacters with particular emphasis on clinical isolates.
Website
-
- Genoscope: French National Sequencing Center; BaumannoScope Project. www.genoscope.cns.fr/agc/mage/baumannoscope.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources